Skip to main content

Table 2 Summary of medication adherence measures in included studies

From: Pharmacist care and the management of coronary heart disease: a systematic review of randomized controlled trials

Source Method of measuring adherence Medication involved Outcome
Calvert [14], 2012 Patient self-report and prescription records assessment Aspirin, β-blocker, and lipid-lowering drug No significant difference in self-reported adherence
Better adherence to β-blocker in prescription assessed adherence in intervention than in control (P = 0.03)
The MEDMAN study [15], 2007 Patient self-report Aspirin, lipid-lowering drug, β-blocker, and ACE inhibitor No significant difference
Faulkner [16], 2000 Pill counts at 6 and 12 weeks and prescription records assessment at 1 and 2 years Lipid-lowering drug No significant difference at 6 or 12 weeks
Medication compliance was significantly higher in intervention than in control (P < 0.05)
Olson [17], 2009 Prescription records assessment Lipid-lowering drug No significant difference
Straka [18], 2005 Prescription records assessment Lipid-lowering drug Medication compliance was higher in intervention than in control (78% versus 44.1%)
  1. Abbreviations: ACE angiotensin-converting enzyme.